Introduction — This topic includes links to society and government-sponsored guidelines from selected countries and regions around the world. We will update these links periodically; newer versions of some guidelines may be available on each society's website. Some societies may require users to log in to access their guidelines.
The recommendations in the following guidelines may vary from those that appear in UpToDate topic reviews. Readers who are looking for UpToDate topic reviews should use the UpToDate search box to find the relevant content.
Links to related guidelines are provided separately. (See "Society guideline links: Growth hormone deficiency and other growth disorders" and "Society guideline links: Contraception" and "Society guideline links: Adolescent sexual health and pregnancy".)
International
●Use of gonadotropin-releasing hormone analogs in children – Update by an international consortium (2019)
Canada
●CPS: Practice point on meeting the needs of adolescent parents and their children (2016)
United States
●American College of Obstetricians and Gynecologists (ACOG): Committee opinion on the screening and management of the hyperandrogenic adolescent (2019, reaffirmed 2020)
●AAP: Policy statement on the unique needs of the adolescent (2019)
●American College of Radiology (ACR): ACR Appropriateness Criteria neuroendocrine imaging (revised 2018)
●AAP: Clinical report on sexual and reproductive health care services in the pediatric setting (2017)
●AAP: Clinical report on evaluation and referral of children with signs of early puberty (2016)
●AAP: Clinical report on menstrual management for adolescents with disabilities (2016)
●AAP: Clinical report on male adolescent sexual and reproductive health care (2011, reaffirmed 2015)
Europe
United Kingdom
●Scottish Paediatric Endocrine Group (SPEG): Clinical guideline on adrenarche – Management of children presenting with signs of early onset pubic hair/body odour/acne (2015, reviewed 2022)
●British Society for Paediatric Endocrinology and Diabetes (BSPED): Position statement on paediatric age assessment (reviewed 2020)
●BSPED: Shared care guidelines – Use of gonadotropin releasing hormone (GnRH) agonists: Triptorelin (reviewed 2019)
●BSPED: Guideline – Testosterone therapy in infancy and adolescence (2016, reviewed 2018)
●BSPED: Guidance statement – Hormone supplementation for pubertal induction in girls (2016)
Australia–New Zealand
آیا می خواهید مدیلیب را به صفحه اصلی خود اضافه کنید؟